Presentation is loading. Please wait.

Presentation is loading. Please wait.

QUALITY INDICATORS FOR HEPATITIS C Michele Hilton Boon Ray Fox, Clare Echlin, Scott Horton, Hepatitis C Project Group.

Similar presentations


Presentation on theme: "QUALITY INDICATORS FOR HEPATITIS C Michele Hilton Boon Ray Fox, Clare Echlin, Scott Horton, Hepatitis C Project Group."— Presentation transcript:

1 QUALITY INDICATORS FOR HEPATITIS C Michele Hilton Boon Ray Fox, Clare Echlin, Scott Horton, Hepatitis C Project Group

2

3 ACT OF SCOTTISH PARLIAMENT (1 APRIL 2011) to enhance and protect the safety and wellbeing of all who use services provided under the health service and independent healthcare services to fulfil both an improvement and scrutiny role (unique in UK) duty to provide information to the public about availability and quality of health services

4 STANDARDS DEVELOPMENT UNIT We identify the key components of high quality health care and develop ways of assessing whether these are being delivered

5 PROJECT CONTEXT Hepatitis C Action Plan Phase II, Action 2 SIGN 92 Other Scottish and UK guidance Sexual Health and BBV Framework

6 WHY INDICATORS? Demonstrates new strategic direction Streamlines development Reflects changing scrutiny environment Supports local ongoing quality improvement Reduces burden of performance assessment

7 PROJECT OBJECTIVES identify the key components of high quality care for hepatitis C prevention, testing, assessment, treatment and support; and develop a minimum set of high-level measures to assess whether this care is being delivered in a person- centred, safe and effective way

8 PROJECT TIMELINE July-Dec 2010 – Scoping Jan-Aug 2011 – Development Aug-Nov 2011 – Consultation and field testing 30 March 2012 – Publication April 2012 – Implementation

9 INDICATOR 1: REDUCTION IN NEWLY- ACQUIRED INFECTIONS 1.1 Proportion of people with named hep C test and recently acquired infection 1.2 Proportion of injecting drug users with anonymous hep C test and recently acquired infection © NHS Photo Library

10 INDICATOR 2: REDUCTION IN RISK AMONG INJECTING DRUG USERS (IDUS) 2.1 Proportion of IDUs sharing injecting equipment 2.2 Proportion of injecting episodes undertaken with sterile injecting equipment © NHS Photo Library

11 INDICATOR 3: REDUCTION IN UNDIAGNOSED INFECTIONS 3.1 Rate of testing by referral source 3.2 Yield from testing by referral source 3.3 Proportion of IDUs unaware of positive status © NHS Photo Library

12 INDICATOR 4: INCREASE IN ASSESSMENT AT SPECIALIST SERVICES 4.1 Proportion of people diagnosed with active infection attending specialist services © NHS Photo Library

13 INDICATOR 5: INCREASE IN EFFECTIVE PROVISION OF ANTIVIRAL THERAPY 5.1 Proportion of antiviral therapy initiations suggested nationally that took place 5.2 Proportion of treatment- naïve patients achieving SVR 5.3 Proportion of treatment- experienced patients achieving SVR © NHS Photo Library

14 INDICATOR 6: QUALITY OF SERVICES FOR PATIENTS NOT RECEIVING ANTIVIRAL THERAPY 6.1 Proportion of patients not in therapy receiving active monitoring in secondary care © Crown Copyright 2009

15 INDICATOR 6 CONTINUED 6.2 Demonstrated implementation and audit of a policy and protocol for follow-up and support of patients who are not in active therapy © Crown Copyright 2009

16 INDICATOR 7: ACCREDITATION OF MCNS 7.1 The NHS board has a hepatitis C managed care network that has been accredited against the criteria in Appendix 2

17 Thank you


Download ppt "QUALITY INDICATORS FOR HEPATITIS C Michele Hilton Boon Ray Fox, Clare Echlin, Scott Horton, Hepatitis C Project Group."

Similar presentations


Ads by Google